Vecura
PricingSolutions
Resources
Vecura

Product

  • Solutions
  • Pricing
  • Referral Program

Company

  • Contact us
  • Academic Research Program

Resources

  • Updates
  • News
  • Insights
  • Use Cases
  • AI4Life Bootcamp
  • Community

Legal

  • Privacy Policy
  • Terms of Service
  • Citation Guidelines
  • Delete Account
  • Trust Center

© 2026 NYB AI. All rights reserved.

All systems operational
Vecura
PricingSolutions
Resources
Back to use cases

Molecular Docking on Vecura: Models, Methods & Use Cases

Every drug begins as a question: does this molecule fit? Molecular docking answers that question computationally by predicting how a small molecule, peptide, or protein settles into a binding site and estimating how tightly it holds. What once required weeks of crystallography or biochemical assay can now be explored in minutes, at scale, before a single compound is synthesized.

Jun 19, 2026

Molecular Docking on Vecura: Models, Methods & Use Cases

Introduction

Every drug begins as a question: does this molecule fit? Molecular docking answers that question computationally by predicting how a small molecule, peptide, or protein settles into a binding site and estimating how tightly it holds. What once required weeks of crystallography or biochemical assay can now be explored in minutes, at scale, before a single compound is synthesized.

Vecura brings together the full spectrum of docking technology, from the battle-tested AutoDock Vina engine to cutting-edge diffusion and flow-matching generative models, in a single, unified platform. Whether you are screening a million-compound library, refining a lead series, or mapping a protein-protein interface, the right docking tool is one click away.

Background

Molecular docking is a computational method that predicts the preferred orientation and binding energy of one molecule (the ligand) when it binds to a second molecule (the receptor, typically a protein) [1]. The process involves two coupled problems: pose sampling — searching the conformational and translational space of the ligand within the binding pocket — and scoring — estimating the free energy of binding for each sampled pose to rank candidates [1].

Scoring functions fall into four broad families:

  • Force-field-based — sum of van der Waals, electrostatic, and torsional terms derived from molecular mechanics.

  • Empirical — regression-fitted terms (H-bonds, hydrophobic contacts, rotatable bonds) calibrated against experimental affinities.

  • Knowledge-based — statistical potentials derived from the frequency of atom-pair contacts in structural databases.

  • Machine/deep learning — convolutional neural networks (CNNs), graph neural networks (GNNs), or diffusion models trained end-to-end on protein–ligand complex data [1, 2].

Modern workflows increasingly combine these approaches — using classical engines for rapid pose generation and ML models for high-accuracy rescoring [2, 3]. 

Why Does It Matter?

Drug discovery is expensive and slow: bringing a single new medicine to market costs an estimated $1–2 billion and takes over a decade. Molecular docking compresses the early-stage hit-identification and lead-optimization phases dramatically [1, 2]:

  • Virtual screening of millions of compounds against a target can be completed in hours on modern hardware, replacing or prioritizing wet-lab high-throughput screening.

  • Lead optimization uses docking to rationalize SAR, predict the effect of substituent changes, and guide medicinal chemistry decisions before synthesis [3].

  • Mechanism elucidation — docking reveals which residues a ligand contacts, explaining selectivity, resistance mutations, and off-target effects.

  • Drug repurposing — existing approved drugs can be rapidly screened against new targets, a strategy that proved critical during the COVID-19 pandemic [1].

Beyond small-molecule drug discovery, docking is central to protein–protein interaction (PPI) modulation, peptide therapeutics, antibody–antigen interface mapping, food science (flavour–receptor interactions), and agrochemical design [2].

The integration of docking with machine learning, AlphaFold-predicted structures, and molecular dynamics simulations is redefining the predictive power and clinical relevance of the field [1, 2, 3].

Molecular Docking Models on Vecura

Use CaseModelWhy
High-Throughput Virtual Screening
First-pass large library screenAutoDock-Vina Gold-standard open-source engine; gradient-optimization search, well-validated empirical scoring, extremely fast and reproducible across thousands of targets.
Improved minimization / custom scoringsminaVina fork with better energy minimization to convergence and support for custom scoring functions and multiple ligand formats.
CNN-enhanced screeninggninasmina fork with CNN-based scoring and pose refinement; better pose quality and enrichment than Vina at modest extra cost.
Accurate Pose Prediction & Cross-Docking
Blind docking (no predefined box)DiffDock Diffusion-based generative model; predicts a pose distribution without requiring a box definition, making it well-suited for blind docking when the site is unknown
Cross-docking with a reference ligandSigmaDockFragment-based SE(3) diffusion model; accepts an optional reference SDF to anchor the pocket — ideal for homologous cross-docking campaigns.
Pose + affinity in one callFlowDockGeometric flow-matching model; accepts sequence or PDB template + SMILES and outputs 3-D complex with integrated affinity estimate.
Binding Affinity Prediction & Rescoring
GNN rescoring of a docked libraryPandaDock SE(3)-equivariant GNN rescorer; Pearson R = 0.88 on PDBbind; exposes universal rescorer and per-complex pKd prediction.
Post-docking bioactivity predictionDTIGNPredicts pKi / pKd / pIC50 directly from a docked complex; converts raw docking scores into interpretable bioactivity units.
Target fishing / polypharmacologyLigTMapLigand similarity + PSOVina docking + ML scoring across 17 target classes (6,000+ proteins); identifies likely targets and predicts affinity.
Protein–Protein Docking
Rigid PPI dockingEquiDock SE(3)-equivariant end-to-end rigid-body PPI docking (ICLR 2022); fast and geometry-aware.
Unified sampling + rankingDFMDockDiffusion model with dual output heads (force prediction + energy ranking); strong on both pose quality and ranking.
Peptide / DNA partners or restraintsLightDockGSO-based framework supporting protein–protein, protein–peptide, and protein–DNA docking with residue-level restraints.
Experimentally guided dockingColabDockIntegrates HDX-MS / cross-linking / mutagenesis restraints into AlphaFold2-Multimer to produce ranked complex structures.
PPI affinity scoringPPAPESM2-3B embeddings + interfacial contact-aware attention; predicts −ΔG and Kd from a PDB complex.
Pocket Identification
Druggable site detection (pre-docking)FPocket (built-in)Detects and ranks binding pockets by druggability score; available via the pocket auto-detection button in any docking form.

*This update is of 18 June, 2026. Vecura’s library of models will continue to grow.

Notes

  • No single model wins universally: chain classical engines for speed with deep-learning models for accuracy and affinity rescoring.

  • Receptor preparation (protonation, missing loops, hydrogens) impacts results as much as model choice; always prepare your structure first.

  • Docking scores are relative, not absolute. Interpret them against a reference ligand or calibrated benchmark, and validate top hits experimentally.

  • Classical models treat the receptor as rigid; for flexible targets (kinases, GPCRs), consider ensemble docking or follow up with molecular dynamics.

  • Deep-learning models like DiffDock support blind docking without a predefined box, ideal when the binding site is unknown.

Conclusion

Molecular docking has evolved from a niche computational curiosity into an indispensable pillar of modern drug discovery and structural biology. The convergence of classical physics-based engines with deep-learning generative models — diffusion, flow-matching, equivariant GNNs — has dramatically improved pose accuracy, affinity prediction, and applicability to previously intractable targets [1, 2, 3].

Vecura consolidates this entire landscape into one platform: from rapid million-compound virtual screens with AutoDock-Vina, to blind pose prediction with DiffDock, to protein–protein interface mapping with EquiDock and ColabDock. Researchers can move seamlessly from pocket identification through docking, rescoring, ADMET profiling, and molecular dynamics — all without leaving the platform.

As AI-driven docking continues to mature, the bottleneck shifts from computation to experimental validation and data quality. Vecura's integrated pipeline — combining the best models with curated public data and ADMET screening — is designed to make that transition as efficient as possible.

References

[1] Classical Docking to Machine Learning Based Docking: Molecular Docking in Drug Discovery.

https://doi.org/10.2174/0115680266424314251204071847

[2] Integrative Computational Chemistry Approaches in Modern Drug Discovery: Advances in Docking, Pharmacophore Modeling, Molecular Dynamics, and Virtual Screening.

https://doi.org/10.3390/pharmaceutics18050565

[3] Innovative Integration of Molecular Docking and Machine Learning for Drug Discovery: From Virtual Screening to Nanomolar Inhibitors.

https://doi.org/10.1039/d5cc06025g

Topics

molecular-dockingdrug-discoverycnn-scoringprotein-ligandstructure-based

On this page

IntroductionBackgroundWhy Does It Matter?Molecular Docking Models on VecuraNotesConclusionReferences

Explore Vecura now.

Bring your own inputs and start exploring what Vecura can do.

Explore Vecura now

Related use cases

Binding site prediction and pocket generation on Vecura

Nov 16, 2026

Protein–Nucleic Acid co-folding and Specificity Prediction on Vecura

Nov 5, 2026

Protein–protein & protein–peptide docking on Vecura

Oct 21, 2026

Vecura

Product

  • Solutions
  • Pricing
  • Referral Program

Company

  • Contact us
  • Academic Research Program

Resources

  • Updates
  • News
  • Insights
  • Use Cases
  • AI4Life Bootcamp
  • Community

Legal

  • Privacy Policy
  • Terms of Service
  • Citation Guidelines
  • Delete Account
  • Trust Center

© 2026 NYB AI. All rights reserved.

All systems operational